NOX 14.3% 8.0¢ noxopharm limited

Lu-PSMA data, page-3

  1. 355 Posts.
    lightbulb Created with Sketch. 58
    reasonable anxieties Zenox, share them, expect a better result.

    But even though a headline number like 16 months might make people nervous, the real value of adjunct Veyonda won’t be apparent from LuPIN until the data is further taken apart and we see how the group on the highest dose of veyonda did.

    and ultimately we’re gonna need a further trial of direct comparison of LuPSMA vs w adjunct, likely 1800mg veyonda. But I expect the data of the 1200mg group will be compelling enough to do that trial.

    so really for me if the Vision result is only 14 months this would surprise on the upside for me as the LuPIN group on 1200mg is very likely to have a better number than 19.7
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.010(14.3%)
Mkt cap ! $23.37M
Open High Low Value Volume
7.0¢ 8.0¢ 7.0¢ $4.207K 56.02K

Buyers (Bids)

No. Vol. Price($)
1 118527 7.5¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 4999 1
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.